ParkinsonCanadaV1, Main, Exploration, bibRecord, 002376

Synthesis and preliminary evaluation of [18F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET

Identifieur interne : 002376 ( Main/Exploration ); précédent : 002375; suivant : 002377

Synthesis and preliminary evaluation of [18F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET

Auteurs : Karin A. Stephenson [Canada] ; Erik M. Van Oosten [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Sylvain Houle [Canada] ; Neil Vasdev [Canada]

Source :

Neurochemistry international [ 0197-0186 ] ; 2008.

RBID : Pascal:08-0520718

Descripteurs français

Pascal (Inist)
- Exaprolol, Formation image, Encéphale, Récepteur β-adrénergique, Tomoscintigraphie, Fluor.
Wicri :
- topic : Fluor.

English descriptors

KwdEn :
- Emission tomography, Encephalon, Exaprolol, Fluorine, Imaging, β-Adrenergic receptor.

Abstract

Cerebral β-adrenergic receptors (β-ARs) are of interest in several disorders including Parkinson's disease, Alzheimer's disease and in particular major depressive disorder. Development of a positron emission tomography (PET) ligand for imaging β-ARs would allow the quantification of these receptors in the living human brain so as to better understand both the pathophysiology of depression and how to improve treatment. Currently there are no radioligands suitable for this purpose. In an attempt to achieve this goal, we prepared [¹⁸F]-labeled (25)-1-(1-fluoropropan-2-ylamino)-3-(2-cyclohexylphenoxy)propan-2-ol (fluoro-Exaprolol; (2S)-1). Radiolabeling with fluorine-18 was accomplished via preparation of a precursor containing a tosyl leaving group (10), and utilizes the 2-oxazolidinone group to simultaneously protect both the amine and hydroxy groups. The oxazolidinone was readily removed with lithium aluminum hydride following a nucleophilic [¹⁸F]-fluoride for tosyl displacement to prepare [¹⁸F]-(25)-1 in 31% radiochemical yield (uncorrected for decay), with >98% radiochemical purity in <1 h. The specific activity of the formulated product was 927 mCi/μmol and the log P (pH 7.4) was 2.97. Preliminary biological evaluations in conscious rats indicated that [¹⁸F]-(25)-1 had good brain uptake for imaging (0.8-1.3% injected dose/gram (% ID/g) of wet tissue, 5 min post-injection of the radiotracer) with a slow washout (>0.5% ID/g at 60 min post-injection) in all brain regions. Pharmacological challenges indicate that the binding is largely non-specific, as administration of Propranolol, authentic (2S)-1, or WAY 100635 prior to injection of [¹⁸F]-(25)-1 did not block uptake of the radiotracer. These results indicate that [¹⁸F]-(25)-1 is not a suitable candidate for PET imaging of cerebral β-ARs.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000610
to stream PascalFrancis, to step Curation: 000700
to stream PascalFrancis, to step Checkpoint: 000511
to stream Main, to step Merge: 002572
to stream Main, to step Curation: 002376

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Synthesis and preliminary evaluation of [<sup>18</sup>
F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET</title>
<author><name sortKey="Stephenson, Karin A" sort="Stephenson, Karin A" uniqKey="Stephenson K" first="Karin A." last="Stephenson">Karin A. Stephenson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Oosten, Erik M" sort="Van Oosten, Erik M" uniqKey="Van Oosten E" first="Erik M." last="Van Oosten">Erik M. Van Oosten</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="03"><s1>Department of Chemistry, University of Toronto, 80 St. George Street</s1>
<s2>Toronto, Ontario M5S 3H6</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5S 3H6</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wilson, Alan A" sort="Wilson, Alan A" uniqKey="Wilson A" first="Alan A." last="Wilson">Alan A. Wilson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meyer, Jeffrey H" sort="Meyer, Jeffrey H" uniqKey="Meyer J" first="Jeffrey H." last="Meyer">Jeffrey H. Meyer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vasdev, Neil" sort="Vasdev, Neil" uniqKey="Vasdev N" first="Neil" last="Vasdev">Neil Vasdev</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0520718</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0520718 INIST</idno>
<idno type="RBID">Pascal:08-0520718</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000610</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000700</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000511</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000511</idno>
<idno type="wicri:doubleKey">0197-0186:2008:Stephenson K:synthesis:and:preliminary</idno>
<idno type="wicri:Area/Main/Merge">002572</idno>
<idno type="wicri:Area/Main/Curation">002376</idno>
<idno type="wicri:Area/Main/Exploration">002376</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Synthesis and preliminary evaluation of [<sup>18</sup>
F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET</title>
<author><name sortKey="Stephenson, Karin A" sort="Stephenson, Karin A" uniqKey="Stephenson K" first="Karin A." last="Stephenson">Karin A. Stephenson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Van Oosten, Erik M" sort="Van Oosten, Erik M" uniqKey="Van Oosten E" first="Erik M." last="Van Oosten">Erik M. Van Oosten</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="03"><s1>Department of Chemistry, University of Toronto, 80 St. George Street</s1>
<s2>Toronto, Ontario M5S 3H6</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5S 3H6</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wilson, Alan A" sort="Wilson, Alan A" uniqKey="Wilson A" first="Alan A." last="Wilson">Alan A. Wilson</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Meyer, Jeffrey H" sort="Meyer, Jeffrey H" uniqKey="Meyer J" first="Jeffrey H." last="Meyer">Jeffrey H. Meyer</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vasdev, Neil" sort="Vasdev, Neil" uniqKey="Vasdev N" first="Neil" last="Vasdev">Neil Vasdev</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre for Addiction and Mental Health, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Department of Psychiatry, University of Toronto, 250 College Street</s1>
<s2>Toronto, Ontario M5T 1R8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Toronto, Ontario M5T 1R8</wicri:noRegion>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Neurochemistry international</title>
<title level="j" type="abbreviated">Neurochem. int.</title>
<idno type="ISSN">0197-0186</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neurochemistry international</title>
<title level="j" type="abbreviated">Neurochem. int.</title>
<idno type="ISSN">0197-0186</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Emission tomography</term>
<term>Encephalon</term>
<term>Exaprolol</term>
<term>Fluorine</term>
<term>Imaging</term>
<term>β-Adrenergic receptor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Exaprolol</term>
<term>Formation image</term>
<term>Encéphale</term>
<term>Récepteur β-adrénergique</term>
<term>Tomoscintigraphie</term>
<term>Fluor</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Fluor</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Cerebral β-adrenergic receptors (β-ARs) are of interest in several disorders including Parkinson's disease, Alzheimer's disease and in particular major depressive disorder. Development of a positron emission tomography (PET) ligand for imaging β-ARs would allow the quantification of these receptors in the living human brain so as to better understand both the pathophysiology of depression and how to improve treatment. Currently there are no radioligands suitable for this purpose. In an attempt to achieve this goal, we prepared [<sup>18</sup>
F]-labeled (25)-1-(1-fluoropropan-2-ylamino)-3-(2-cyclohexylphenoxy)propan-2-ol (fluoro-Exaprolol; (2S)-1). Radiolabeling with fluorine-18 was accomplished via preparation of a precursor containing a tosyl leaving group (10), and utilizes the 2-oxazolidinone group to simultaneously protect both the amine and hydroxy groups. The oxazolidinone was readily removed with lithium aluminum hydride following a nucleophilic [<sup>18</sup>
F]-fluoride for tosyl displacement to prepare [<sup>18</sup>
F]-(25)-1 in 31% radiochemical yield (uncorrected for decay), with >98% radiochemical purity in <1 h. The specific activity of the formulated product was 927 mCi/μmol and the log P (pH 7.4) was 2.97. Preliminary biological evaluations in conscious rats indicated that [<sup>18</sup>
F]-(25)-1 had good brain uptake for imaging (0.8-1.3% injected dose/gram (% ID/g) of wet tissue, 5 min post-injection of the radiotracer) with a slow washout (>0.5% ID/g at 60 min post-injection) in all brain regions. Pharmacological challenges indicate that the binding is largely non-specific, as administration of Propranolol, authentic (2S)-1, or WAY 100635 prior to injection of [<sup>18</sup>
F]-(25)-1 did not block uptake of the radiotracer. These results indicate that [<sup>18</sup>
F]-(25)-1 is not a suitable candidate for PET imaging of cerebral β-ARs.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Stephenson, Karin A" sort="Stephenson, Karin A" uniqKey="Stephenson K" first="Karin A." last="Stephenson">Karin A. Stephenson</name>
</noRegion>
<name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name>
<name sortKey="Meyer, Jeffrey H" sort="Meyer, Jeffrey H" uniqKey="Meyer J" first="Jeffrey H." last="Meyer">Jeffrey H. Meyer</name>
<name sortKey="Meyer, Jeffrey H" sort="Meyer, Jeffrey H" uniqKey="Meyer J" first="Jeffrey H." last="Meyer">Jeffrey H. Meyer</name>
<name sortKey="Stephenson, Karin A" sort="Stephenson, Karin A" uniqKey="Stephenson K" first="Karin A." last="Stephenson">Karin A. Stephenson</name>
<name sortKey="Van Oosten, Erik M" sort="Van Oosten, Erik M" uniqKey="Van Oosten E" first="Erik M." last="Van Oosten">Erik M. Van Oosten</name>
<name sortKey="Van Oosten, Erik M" sort="Van Oosten, Erik M" uniqKey="Van Oosten E" first="Erik M." last="Van Oosten">Erik M. Van Oosten</name>
<name sortKey="Vasdev, Neil" sort="Vasdev, Neil" uniqKey="Vasdev N" first="Neil" last="Vasdev">Neil Vasdev</name>
<name sortKey="Vasdev, Neil" sort="Vasdev, Neil" uniqKey="Vasdev N" first="Neil" last="Vasdev">Neil Vasdev</name>
<name sortKey="Wilson, Alan A" sort="Wilson, Alan A" uniqKey="Wilson A" first="Alan A." last="Wilson">Alan A. Wilson</name>
<name sortKey="Wilson, Alan A" sort="Wilson, Alan A" uniqKey="Wilson A" first="Alan A." last="Wilson">Alan A. Wilson</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002376 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002376 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:08-0520718
   |texte=   Synthesis and preliminary evaluation of [18F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Synthesis and preliminary evaluation of [18F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET

Synthesis and preliminary evaluation of [18F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri